Replies to post #119362 on Biotech Values

[DewDiligence]

AGN—I almost forgot to mention that the stock steamrolled to an all-time high today (81.87, +4%).

[DewDiligence]

AGN set all-time intraday and closing highs today. It is (IMO) one of the best pharma plays on The Global Demographic Tailwind (#msg-62753229).

[DewDiligence]

AGN buys private company for $75M (plus $200M earnout):

http://finance.yahoo.com/news/Allergan-Inc-to-Acquire-bw-507898799.html?x=0&.v=1

Founded in 2009 and backed by Vivo Ventures, Fidelity Biosciences and Sofinnova Ventures, Vicept Therapeutics’ lead investigational product, V-101, is a topical cream for the treatment of the erythema (redness) associated with rosacea that has achieved positive results in two randomized, placebo-controlled Phase II studies.

[DewDiligence]

How perceptions about Botox for cosmetic indications have changed during the past decade:

http://finance.yahoo.com/news/Awardwinning-Actress-Courtney-prnews-3879465155.html?x=0&.v=1

• The number of women considering talking to their doctors about BOTOX® Cosmetic treatment more than quadrupled from 1.3 million in 2002 to 5.8 million in 2010.

• The number of women who think that BOTOX® Cosmetic is an effective means for treating frown lines between the eyebrows has increased from 21 percent when the product was approved to 79 percent in 2010.